NVO logo

Novo Nordisk A/S (NVO) Short term debt

Annual short term debt:

$1.83B+$867.68M(+90.21%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVO annual short term debt is $1.83 billion, with the most recent change of +$867.68 million (+90.21%) on December 31, 2024.
  • During the last 3 years, NVO annual short term debt has fallen by -$253.71 million (-12.18%).
  • NVO annual short term debt is now -12.18% below its all-time high of $2.08 billion, reached on December 31, 2021.

Performance

NVO Short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly short term debt:

$3.25B+$1.42B(+77.71%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVO quarterly short term debt is $3.25 billion, with the most recent change of +$1.42 billion (+77.71%) on March 31, 2025.
  • Over the past year, NVO quarterly short term debt has increased by +$1.78 billion (+121.13%).
  • NVO quarterly short term debt is now at all-time high.

Performance

NVO quarterly short term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Short term debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

NVO Short term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+90.2%+121.1%
3 y3 years-12.2%+1452.0%
5 y5 years+727.9%+1669.6%

NVO Short term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.2%+767.1%at high+1743.7%
5 y5-year-12.2%+767.1%at high+1743.7%
alltimeall time-12.2%>+9999.0%at high>+9999.0%

NVO Short term debt History

DateAnnualQuarterly
Mar 2025
-
$3.25B(+77.7%)
Dec 2024
$1.83B(+90.2%)
$1.83B(+121.3%)
Sep 2024
-
$826.80M(+5.6%)
Jun 2024
-
$782.65M(-46.8%)
Mar 2024
-
$1.47B(+52.9%)
Dec 2023
$961.80M(+355.8%)
$961.80M(+2.7%)
Sep 2023
-
$936.59M(+2.1%)
Jun 2023
-
$917.75M(+401.2%)
Mar 2023
-
$183.13M(-13.2%)
Dec 2022
$211.00M(-89.9%)
$211.00M(-12.9%)
Sep 2022
-
$242.27M(+37.4%)
Jun 2022
-
$176.34M(-15.8%)
Mar 2022
-
$209.49M(-89.9%)
Dec 2021
$2.08B(+69.0%)
$2.08B(+889.1%)
Sep 2021
-
$210.62M(+1.2%)
Jun 2021
-
$208.20M(-80.6%)
Mar 2021
-
$1.08B(-12.8%)
Dec 2020
$1.23B(+457.9%)
$1.23B(+432.6%)
Sep 2020
-
$231.47M(+9.0%)
Jun 2020
-
$212.40M(+15.6%)
Mar 2020
-
$183.72M(-16.9%)
Dec 2019
$220.99M(+180.1%)
$220.99M(+6.5%)
Sep 2019
-
$207.50M(+8.5%)
Jun 2019
-
$191.19M(+14.2%)
Mar 2019
-
$167.41M(+112.2%)
Dec 2018
$78.89M(-71.1%)
$78.89M(+50.5%)
Sep 2018
-
$52.43M(+36.9%)
Jun 2018
-
$38.31M(+1.6%)
Mar 2018
-
$37.69M(-86.2%)
Dec 2017
$272.99M(+738.3%)
$272.99M(+563.4%)
Sep 2017
-
$41.15M(-84.1%)
Jun 2017
-
$258.90M(+194.0%)
Mar 2017
-
$88.06M(+170.4%)
Dec 2016
$32.57M(-79.3%)
$32.57M(-52.5%)
Sep 2016
-
$68.63M(+13.1%)
Jun 2016
-
$60.71M(-1.7%)
Mar 2016
-
$61.73M(-60.7%)
Dec 2015
$157.17M(+33.7%)
$157.17M(+65.4%)
Sep 2015
-
$95.03M(-14.1%)
Jun 2015
-
$110.64M(+28.5%)
Mar 2015
-
$86.11M(-26.7%)
Dec 2014
$117.55M(+195.4%)
$117.55M(+142.8%)
Sep 2014
-
$48.41M(-34.8%)
Jun 2014
-
$74.28M(-49.8%)
Mar 2014
-
$148.04M(+272.0%)
Dec 2013
$39.79M(-55.1%)
$39.79M(-67.2%)
Sep 2013
-
$121.22M(-3.1%)
Jun 2013
-
$125.11M(+142.6%)
Mar 2013
-
$51.56M(-41.8%)
Dec 2012
$88.62M
$88.62M(-13.0%)
Sep 2012
-
$101.81M(+56.8%)
Jun 2012
-
$64.94M(-5.3%)
DateAnnualQuarterly
Mar 2012
-
$68.54M(+12.1%)
Dec 2011
$61.17M(-80.1%)
$61.17M(-80.2%)
Sep 2011
-
$308.81M(+79.8%)
Jun 2011
-
$171.74M(-10.0%)
Mar 2011
-
$190.80M(-37.8%)
Dec 2010
$306.83M(+281.6%)
$306.83M(+67.7%)
Sep 2010
-
$182.98M(-65.9%)
Jun 2010
-
$536.44M(+185.4%)
Mar 2010
-
$187.93M(+133.7%)
Dec 2009
$80.40M(-68.0%)
$80.40M(+78.4%)
Sep 2009
-
$45.06M(-47.2%)
Jun 2009
-
$85.38M(-66.9%)
Mar 2009
-
$257.94M(+2.8%)
Dec 2008
$250.96M(+217.6%)
$250.96M(+65.1%)
Sep 2008
-
$152.04M(+55.1%)
Jun 2008
-
$98.06M(-24.9%)
Mar 2008
-
$130.64M(+65.4%)
Dec 2007
$79.01M(+31.8%)
$79.01M(+172.6%)
Sep 2007
-
$28.98M(+61.0%)
Jun 2007
-
$18.00M(-48.6%)
Mar 2007
-
$35.00M(-41.6%)
Dec 2006
$59.97M(-73.8%)
$59.97M(+17.6%)
Sep 2006
-
$51.00M(-8.9%)
Jun 2006
-
$55.95M(-70.7%)
Mar 2006
-
$190.79M(-16.7%)
Dec 2005
$229.00M(+146.5%)
$229.00M(+66.0%)
Sep 2005
-
$137.92M(+42.4%)
Jun 2005
-
$96.86M(+30.8%)
Mar 2005
-
$74.04M(-20.3%)
Dec 2004
$92.91M(-43.7%)
$92.91M(+27.2%)
Sep 2004
-
$73.02M(-10.9%)
Jun 2004
-
$81.91M(-37.4%)
Mar 2004
-
$130.91M(-20.7%)
Dec 2003
$165.01M(+106.4%)
$165.01M(+106.4%)
Dec 2002
$79.93M(-18.4%)
$79.93M(-18.4%)
Dec 2001
$98.01M(-3.9%)
$98.01M(-3.9%)
Dec 2000
$102.01M(-24.3%)
$102.01M(-24.3%)
Dec 1999
$134.70M(-6.9%)
$134.70M(-6.9%)
Dec 1998
$144.65M(-26.4%)
$144.65M(-26.4%)
Dec 1997
$196.55M(-13.6%)
$196.55M(-13.6%)
Dec 1996
$227.43M(+74.0%)
$227.43M(+74.0%)
Dec 1995
$130.69M(-45.4%)
$130.69M(-45.4%)
Dec 1994
$239.22M(+68.7%)
$239.22M(+68.7%)
Dec 1993
$141.82M(-11.0%)
$141.82M(-11.0%)
Dec 1992
$159.33M(-30.6%)
$159.33M(-30.6%)
Dec 1991
$229.50M(-22.8%)
$229.50M(-22.8%)
Dec 1990
$297.39M(+8.7%)
$297.39M(+8.7%)
Dec 1989
$273.58M(+49.4%)
$273.58M(+49.4%)
Dec 1988
$183.09M(+6.9%)
$183.09M(+6.9%)
Dec 1987
$171.23M(+1916.5%)
$171.23M(+1916.5%)
Dec 1986
$8.49M(+19.7%)
$8.49M(+19.7%)
Dec 1985
$7.10M(-91.8%)
$7.10M(-91.8%)
Dec 1984
$86.36M
$86.36M

FAQ

  • What is Novo Nordisk A/S annual short term debt?
  • What is the all time high annual short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual short term debt year-on-year change?
  • What is Novo Nordisk A/S quarterly short term debt?
  • What is the all time high quarterly short term debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly short term debt year-on-year change?

What is Novo Nordisk A/S annual short term debt?

The current annual short term debt of NVO is $1.83B

What is the all time high annual short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual short term debt is $2.08B

What is Novo Nordisk A/S annual short term debt year-on-year change?

Over the past year, NVO annual short term debt has changed by +$867.68M (+90.21%)

What is Novo Nordisk A/S quarterly short term debt?

The current quarterly short term debt of NVO is $3.25B

What is the all time high quarterly short term debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly short term debt is $3.25B

What is Novo Nordisk A/S quarterly short term debt year-on-year change?

Over the past year, NVO quarterly short term debt has changed by +$1.78B (+121.13%)
On this page